Kezar Life Sciences Inc (KZR)

Currency in USD
4.330
-0.030(-0.69%)
Closed·
After Hours
4.410+0.080(+1.85%)
·
KZR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
KZR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.2504.410
52 wk Range
3.6209.180
Key Statistics
Prev. Close
4.33
Open
4.35
Day's Range
4.25-4.41
52 wk Range
3.62-9.18
Volume
48.25K
Average Volume (3m)
51.19K
1-Year Change
-36.35%
Book Value / Share
14.11
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KZR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.500
Upside
+188.68%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Kezar Life Sciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Kezar Life Sciences Inc Company Profile

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company’s lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Compare KZR to Peers and Sector

Metrics to compare
KZR
Peers
Sector
Relationship
P/E Ratio
−0.4x−4.5x−0.5x
PEG Ratio
−0.020.020.00
Price/Book
0.3x3.1x2.6x
Price / LTM Sales
-192.5x3.2x
Upside (Analyst Target)
188.7%167.9%42.0%
Fair Value Upside
Unlock8.1%6.6%Unlock

Analyst Ratings

3 Buy
3 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 12.500
(+188.68% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-2.27 / -0.285
Revenue / Forecast
-- / 2.50M
EPS Revisions
Last 90 days

KZR Income Statement

People Also Watch

268.39
AVAV
-0.83%
13.2500
CYCC
-13.91%
1.200
AEMD
-6.25%
6.37
KURA
+2.74%
1.470
CTXR
-4.55%

FAQ

What Stock Exchange Does Kezar Life Trade On?

Kezar Life is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Kezar Life?

The stock symbol for Kezar Life is "KZR."

What Is the Kezar Life Market Cap?

As of today, Kezar Life market cap is 31.63M.

What Is Kezar Life's Earnings Per Share (TTM)?

The Kezar Life EPS (TTM) is -10.78.

From a Technical Analysis Perspective, Is KZR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Kezar Life Stock Split?

Kezar Life has split 1 times.

How Many Employees Does Kezar Life Have?

Kezar Life has 55 employees.

What is the current trading status of Kezar Life (KZR)?

As of 30 Jul 2025, Kezar Life (KZR) is trading at a price of 4.33, with a previous close of 4.33. The stock has fluctuated within a day range of 4.25 to 4.41, while its 52-week range spans from 3.62 to 9.18.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.